Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127845) titled 'A prospective, open, exploratory clinical trial to evaluate the efficacy and safety of different time-fractionation regimens of tumor treating fields combined with temozolomide for newly diagnosed glioblastoma after surgery and concurrent chemoradiotherapy' on July 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Glioblastoma
Intervention:
Group A:Tumor treating fields (MF-I-100B) >=18 hours/day + temozolomide adjuvant chemotherapy for 6 cycles
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-07-09
Tar...